期刊文献+

肿瘤坏死因子-α、B细胞刺激因子、细胞间黏附分子-1、血管细胞黏附分子-1在原发性舍格伦综合征患者血清中的水平变化 被引量:4

Expression of TNF-α、BAFF 、ICAM-1、VCAM-1 in the serum of patients with primary Sjgeren's syndrome
下载PDF
导出
摘要 目的探讨原发性舍格伦综合征(primary Sjgeren’s syndrome,p SS)患者血清中肿瘤坏死因子(TNF-α)、B细胞刺激因子(BAFF)、细胞间黏附分子-1(ICAM-1)、血管细胞黏附分子-1(VCAM-1)的表达意义,为p SS的临床治疗提供实验依据。方法选择经病理确诊的p SS患者50例,酶联免疫吸附试验(ELISA)检测患者血清中TNF-α、BAFF、ICAM-1、VCAM-1的含量,并利用SPSS软件包对数据进行统计学分析。结果 p SS患者血清中TNF-α、BAFF、ICAM-1、VCAM-1的含量较正常对照组显著升高(P<0.05)。结论细胞因子TNF-α、BAFF、ICAM-1、VCAM-1可能参与了p SS的发生发展过程,其相互作用关系有待进一步研究。 Obejetive To explore the expression of TNF-α,BAFF,ICAM-1 and VCAM-1 in the serum of patients with primary Sjgeren's syndrome and to provide experimental basis for clinical treatment of p SS. Methods Fifty primary Sjgeren's syndrome patients were diagnosed by pathological examination. Serum expression levels of TNF-α,BAFF,ICAM-1 and VCAM-1 were detected by enzyme linked immunosorbent assay( ELISA). The software SPSS was used for statistical analysis. Results The expression levels of TNF-α,BAFF,ICAM-1 and VCAM-1 obviously increased in serum of p SS patients compared with healthy subjects( P 0. 05). Conclusion TNF-α,BAFF,ICAM-1 and VCAM-1 may be involved in the occurrence and development of p SS,and the exact interactions between them still need further research.
作者 邓剑兰 范媛 DENG Jianlan FAN Yuan(Jiangsu Key Laboratory of Oral Diseases, Nanfing Medical University, Nanjing 210029, China)
出处 《口腔医学》 CAS 2016年第11期1011-1013,共3页 Stomatology
基金 国家自然科学基金(81170961) 江苏高校优势学科建设工程资助项目(2014-37)
  • 相关文献

参考文献6

二级参考文献81

  • 1王雪松,阮旭中,刘买利.银杏叶提取物(GBE)对大鼠局灶性脑缺血后细胞间黏附分子-1及其mRNA表达的影响[J].中国现代应用药学,2003,20(6):441-444. 被引量:16
  • 2王文安,周永炜,程洁,王根发,陈兴华.三七皂甙对局灶性脑缺血再灌注后MMP-9表达的影响[J].上海第二医科大学学报,2004,24(9):731-733. 被引量:11
  • 3Sorian SG, Lipton SA, Wang Y'F, et al. Intercellular adhesion moleeule -1 (ICAM-l) - deficient mice areless suspetible to crerbral ischemia - reperfusion injury. Neurol, 1996,39(5):618-624.
  • 4郑义,刘永东,等.脑梗死患者可溶性ICAM-I\VCAM一1水平变化及临床意义[J].中国神经疾病杂志,2008,12(6):214-216.
  • 5王晓翔,程赣萍.急性脑梗死患者血清TNF-\VCAM-1含量变化及临床意义[J].中国神经疾病杂志,2010,25(4):198-200.
  • 6Dietz A B,Padley D J,Gastineau D A. Infrastructure development for human cell therapy translation[J].Clin Pharmacol Ther,2007,82(3):320-323.
  • 7Ruster B. Gottig S, Ludwig R J, et al. Mesenchymal stem cells (MSCs) display coordinated rolling and adhesion behavior on endothelial cells [J]. Blood,2006, 108(12):3938-3944.
  • 8J Vincent F M S, Ivan V R, Luc J A, et al. Mesenehymal stem cell adllesion to cardiac microvascular endothelittm: activators and mechanisms [J]. Am J Physiol Heart Circ Physiol,2006,290(4): 1370-1377.
  • 9Daniel A D U, Zeni A, Patricia A Z, et al. Differential expression of stem cell mobilization-associated molecules on multi-Jineage cells from adipose tissue and bone marrow[J].Immunol Lett,2003,89(2-3):267-270.
  • 10Manas K Michele M, Diana K M, et, al. Characterization and functionality of cell surface molecules on human mesenehymal stem cells. J Biomed Sc,2003,10(2):228-241.

共引文献27

同被引文献55

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部